$VRUS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pharmasset Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pharmasset Inc. Get notifications about new insider transactions in Pharmasset Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.50 | 600 | 11,100 | 3,300 | 3.9 K to 3.3 K (-15.38 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.43 | 300 | 5,529 | 3,900 | 4.2 K to 3.9 K (-7.14 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.40 | 300 | 5,520 | 4,200 | 4.5 K to 4.2 K (-6.67 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.39 | 70 | 1,287 | 4,500 | 4.6 K to 4.5 K (-1.53 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.38 | 100 | 1,838 | 4,570 | 4.7 K to 4.6 K (-2.14 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.37 | 100 | 1,837 | 4,670 | 4.8 K to 4.7 K (-2.10 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.35 | 1,430 | 26,241 | 4,770 | 6.2 K to 4.8 K (-23.06 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.32 | 400 | 7,328 | 6,200 | 6.6 K to 6.2 K (-6.06 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.29 | 300 | 5,487 | 6,600 | 6.9 K to 6.6 K (-4.35 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.27 | 400 | 7,308 | 6,900 | 7.3 K to 6.9 K (-5.48 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.26 | 400 | 7,304 | 7,300 | 7.7 K to 7.3 K (-5.19 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.25 | 1,672 | 30,514 | 7,700 | 9.4 K to 7.7 K (-17.84 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.24 | 600 | 10,944 | 9,372 | 10 K to 9.4 K (-6.02 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.23 | 100 | 1,823 | 9,972 | 10.1 K to 10 K (-0.99 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.21 | 600 | 10,926 | 10,072 | 10.7 K to 10.1 K (-5.62 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.20 | 120 | 2,184 | 10,692 | 10.8 K to 10.7 K (-1.11 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.14 | 600 | 10,884 | 10,792 | 11.4 K to 10.8 K (-5.27 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.13 | 200 | 3,626 | 11,392 | 11.6 K to 11.4 K (-1.73 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.12 | 1,080 | 19,570 | 11,592 | 12.7 K to 11.6 K (-8.52 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.10 | 100 | 1,810 | 12,672 | 12.8 K to 12.7 K (-0.78 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.08 | 200 | 3,616 | 12,772 | 13 K to 12.8 K (-1.54 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.07 | 400 | 7,228 | 12,972 | 13.4 K to 13 K (-2.99 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.05 | 400 | 7,220 | 13,372 | 13.8 K to 13.4 K (-2.90 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.02 | 400 | 7,208 | 13,772 | 14.2 K to 13.8 K (-2.82 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.00 | 2,500 | 45,000 | 14,172 | 16.7 K to 14.2 K (-15.00 %) |
| Nov 17 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Buy | M | 13.88 | 16,672 | 231,407 | 16,672 | 0 to 16.7 K |
| Oct 27 2008 | VRUS | Pharmasset Inc | LUBETKIN PAUL | Executive VP & Gene ... | Option Exercise | A | 19.81 | 50,000 | 990,500 | 50,000 | |
| Nov 05 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | M | 13.88 | 500 | 6,940 | 72,922 | |
| Nov 05 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Option Exercise | M | 13.88 | 1,578 | 21,903 | 73,422 | |
| Nov 05 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.25 | 400 | 7,300 | 0 | 400 to 0 (-100.00 %) |
| Nov 05 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.02 | 100 | 1,802 | 400 | 500 to 400 (-20.00 %) |
| Nov 05 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Buy | M | 13.88 | 500 | 6,940 | 500 | 0 to 500 |
| Nov 05 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Sell | S | 18.00 | 1,578 | 28,404 | 0 | 1.6 K to 0 (-100.00 %) |
| Nov 05 2008 | VRUS | Pharmasset Inc | Rogers Michael D. | Chief Development O ... | Buy | M | 13.88 | 1,578 | 21,903 | 1,578 | 0 to 1.6 K |
| Sep 26 2008 | VRUS | Pharmasset Inc | Carney William J | Director | Grant | A | 0.00 | 2,000 | 0 | 59,166 | 57.2 K to 59.2 K (+3.50 %) |
| Sep 26 2008 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 17,919 | 15.9 K to 17.9 K (+12.56 %) |
| Sep 26 2008 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 26 2008 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Grant | A | 0.00 | 2,000 | 0 | 15,333 | 13.3 K to 15.3 K (+15.00 %) |
| Sep 26 2008 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 26 2008 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Grant | A | 0.00 | 2,000 | 0 | 8,667 | 6.7 K to 8.7 K (+30.00 %) |
| Sep 26 2008 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 19 2008 | VRUS | Pharmasset Inc | INOUYE MICHAEL K | Director | Option Exercise | A | 20.20 | 10,000 | 202,000 | 10,000 | |
| Sep 19 2008 | VRUS | Pharmasset Inc | BURRILL STEVEN | Director | Option Exercise | A | 20.20 | 10,000 | 202,000 | 10,000 | |
| Sep 19 2008 | VRUS | Pharmasset Inc | Carney William J | Director | Option Exercise | A | 20.20 | 10,000 | 202,000 | 10,000 | |
| Sep 19 2008 | VRUS | Pharmasset Inc | CONRAD HERBERT J | Director | Option Exercise | A | 20.20 | 10,000 | 202,000 | 10,000 | |
| Sep 19 2008 | VRUS | Pharmasset Inc | Williamson Robert F III | Director | Option Exercise | A | 20.20 | 10,000 | 202,000 | 10,000 | |
| Sep 19 2008 | VRUS | Pharmasset Inc | HAHN ELLIOT F | Director | Option Exercise | A | 20.20 | 10,000 | 202,000 | 10,000 | |
| Sep 19 2008 | VRUS | Pharmasset Inc | PRICE FREDRIC D | Director | Option Exercise | A | 20.20 | 10,000 | 202,000 | 10,000 | |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Option Exercise | M | 3.00 | 5,835 | 17,505 | 0 | |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.82 | 22 | 480 | 19,500 | 19.5 K to 19.5 K (-0.11 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.80 | 700 | 15,260 | 19,522 | 20.2 K to 19.5 K (-3.46 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.78 | 100 | 2,178 | 20,222 | 20.3 K to 20.2 K (-0.49 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.77 | 100 | 2,177 | 20,322 | 20.4 K to 20.3 K (-0.49 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.70 | 100 | 2,170 | 20,422 | 20.5 K to 20.4 K (-0.49 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.66 | 157 | 3,401 | 20,522 | 20.7 K to 20.5 K (-0.76 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.64 | 300 | 6,492 | 20,679 | 21 K to 20.7 K (-1.43 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.56 | 300 | 6,468 | 20,979 | 21.3 K to 21 K (-1.41 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.50 | 200 | 4,300 | 21,279 | 21.5 K to 21.3 K (-0.93 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.49 | 300 | 6,447 | 21,479 | 21.8 K to 21.5 K (-1.38 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.47 | 100 | 2,147 | 21,779 | 21.9 K to 21.8 K (-0.46 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.43 | 800 | 17,144 | 21,879 | 22.7 K to 21.9 K (-3.53 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.41 | 100 | 2,141 | 22,679 | 22.8 K to 22.7 K (-0.44 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.40 | 100 | 2,140 | 22,779 | 22.9 K to 22.8 K (-0.44 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.38 | 300 | 6,414 | 22,879 | 23.2 K to 22.9 K (-1.29 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.32 | 400 | 8,528 | 23,179 | 23.6 K to 23.2 K (-1.70 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.11 | 100 | 2,111 | 23,579 | 23.7 K to 23.6 K (-0.42 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.07 | 156 | 3,287 | 23,679 | 23.8 K to 23.7 K (-0.65 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Sell | S | 21.06 | 1,500 | 31,590 | 23,835 | 25.3 K to 23.8 K (-5.92 %) |
| Aug 13 2008 | VRUS | Pharmasset Inc | OTTO MICHAEL | Chief Scientific Of ... | Buy | M | 3.00 | 5,835 | 17,505 | 25,335 | 19.5 K to 25.3 K (+29.92 %) |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 20.10 | 9 | 181 | 2,089,394 | 2.1 M to 2.1 M (0.00 %) | |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 20.06 | 300 | 6,018 | 2,089,403 | 2.1 M to 2.1 M (-0.01 %) | |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 20.00 | 200 | 4,000 | 2,089,703 | 2.1 M to 2.1 M (-0.01 %) | |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.97 | 400 | 7,988 | 2,089,903 | 2.1 M to 2.1 M (-0.02 %) | |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.94 | 100 | 1,994 | 2,090,303 | 2.1 M to 2.1 M (0.00 %) | |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.93 | 1,628 | 32,446 | 2,090,403 | 2.1 M to 2.1 M (-0.08 %) | |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.92 | 100 | 1,992 | 2,092,031 | 2.1 M to 2.1 M (0.00 %) | |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.91 | 100 | 1,991 | 2,092,131 | 2.1 M to 2.1 M (0.00 %) | |
| Jun 24 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | Sell | S | 19.90 | 26,100 | 519,390 | 2,092,231 | 2.1 M to 2.1 M (-1.23 %) | |
| Jun 23 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | Sell | S | 20.00 | 1,400 | 28,000 | 2,118,331 | 2.1 M to 2.1 M (-0.07 %) | |
| Jun 23 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | Sell | S | 19.94 | 100 | 1,994 | 2,119,731 | 2.1 M to 2.1 M (0.00 %) | |
| Jun 23 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | Sell | S | 19.92 | 100 | 1,992 | 2,119,831 | 2.1 M to 2.1 M (0.00 %) | |
| Jun 23 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | Sell | S | 19.91 | 500 | 9,955 | 2,119,931 | 2.1 M to 2.1 M (-0.02 %) | |
| Jun 23 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | Sell | S | 19.90 | 153,700 | 3,058,630 | 2,120,431 | 2.3 M to 2.1 M (-6.76 %) | |
| Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 20.00 | 1,400 | 28,000 | 2,118,331 | 2.1 M to 2.1 M (-0.07 %) |
| Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 19.94 | 100 | 1,994 | 2,119,731 | 2.1 M to 2.1 M (0.00 %) |
| Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 19.92 | 100 | 1,992 | 2,119,831 | 2.1 M to 2.1 M (0.00 %) |
| Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 19.91 | 500 | 9,955 | 2,119,931 | 2.1 M to 2.1 M (-0.02 %) |
| Jun 23 2008 | VRUS | Pharmasset Inc | EVNIN LUKE | 10% Owner | Sell | S | 19.90 | 153,700 | 3,058,630 | 2,120,431 | 2.3 M to 2.1 M (-6.76 %) |
| Jun 23 2008 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Option Exercise | M | 4.20 | 2,976 | 12,499 | 59,524 | |
| Jun 23 2008 | VRUS | Pharmasset Inc | Berrey M Michelle | Chief Medical Offic ... | Buy | M | 4.20 | 2,976 | 12,499 | 2,976 | 0 to 3 K |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.46 | 9 | 184 | 2,376,031 | 2.4 M to 2.4 M (0.00 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.45 | 100 | 2,045 | 2,376,040 | 2.4 M to 2.4 M (0.00 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.44 | 200 | 4,088 | 2,376,140 | 2.4 M to 2.4 M (-0.01 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.43 | 300 | 6,129 | 2,376,340 | 2.4 M to 2.4 M (-0.01 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.42 | 100 | 2,042 | 2,376,640 | 2.4 M to 2.4 M (0.00 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.41 | 100 | 2,041 | 2,376,740 | 2.4 M to 2.4 M (0.00 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.40 | 1,200 | 24,480 | 2,376,840 | 2.4 M to 2.4 M (-0.05 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.39 | 500 | 10,195 | 2,378,040 | 2.4 M to 2.4 M (-0.02 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.38 | 200 | 4,076 | 2,378,540 | 2.4 M to 2.4 M (-0.01 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.37 | 200 | 4,074 | 2,378,740 | 2.4 M to 2.4 M (-0.01 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.36 | 400 | 8,144 | 2,378,940 | 2.4 M to 2.4 M (-0.02 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.35 | 300 | 6,105 | 2,379,340 | 2.4 M to 2.4 M (-0.01 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.34 | 800 | 16,272 | 2,379,640 | 2.4 M to 2.4 M (-0.03 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.33 | 600 | 12,198 | 2,380,440 | 2.4 M to 2.4 M (-0.03 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.32 | 25,000 | 508,000 | 2,381,040 | 2.4 M to 2.4 M (-1.04 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.31 | 4,341 | 88,166 | 2,406,040 | 2.4 M to 2.4 M (-0.18 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.30 | 33,666 | 683,420 | 2,410,381 | 2.4 M to 2.4 M (-1.38 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.29 | 908 | 18,423 | 2,444,047 | 2.4 M to 2.4 M (-0.04 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.28 | 824 | 16,711 | 2,444,955 | 2.4 M to 2.4 M (-0.03 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.27 | 1,850 | 37,500 | 2,445,779 | 2.4 M to 2.4 M (-0.08 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.26 | 2,124 | 43,032 | 2,447,629 | 2.4 M to 2.4 M (-0.09 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.25 | 19,656 | 398,034 | 2,449,753 | 2.5 M to 2.4 M (-0.80 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.24 | 160 | 3,238 | 2,469,409 | 2.5 M to 2.5 M (-0.01 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.22 | 548 | 11,081 | 2,469,569 | 2.5 M to 2.5 M (-0.02 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.20 | 3,176 | 64,155 | 2,470,117 | 2.5 M to 2.5 M (-0.13 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.08 | 200 | 4,016 | 2,473,293 | 2.5 M to 2.5 M (-0.01 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.06 | 100 | 2,006 | 2,473,493 | 2.5 M to 2.5 M (0.00 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.05 | 183,587 | 3,680,919 | 2,473,593 | 2.7 M to 2.5 M (-6.91 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.25 | 1,900 | 38,475 | 2,274,131 | 2.3 M to 2.3 M (-0.08 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.17 | 100 | 2,017 | 2,276,031 | 2.3 M to 2.3 M (0.00 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.16 | 100 | 2,016 | 2,276,131 | 2.3 M to 2.3 M (0.00 %) |
| Jun 18 2008 | VRUS | Pharmasset Inc | BB BIOVENTURES L P | 10% Owner | Sell | S | 20.15 | 99,800 | 2,010,970 | 2,276,231 | 2.4 M to 2.3 M (-4.20 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.38 | 18 | 349 | 0 | 18 to 0 (-100.00 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.38 | 82 | 1,589 | 0 | 82 to 0 (-100.00 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.37 | 17 | 329 | 18 | 35 to 18 (-48.57 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.37 | 83 | 1,608 | 82 | 165 to 82 (-50.30 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.11 | 9 | 172 | 35 | 44 to 35 (-20.45 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.11 | 41 | 784 | 165 | 206 to 165 (-19.90 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.08 | 17 | 324 | 44 | 61 to 44 (-27.87 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.08 | 83 | 1,584 | 206 | 289 to 206 (-28.72 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.00 | 3,242 | 61,598 | 61 | 3.3 K to 61 (-98.15 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.00 | 15,387 | 292,353 | 289 | 15.7 K to 289 (-98.16 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.00 | 230 | 4,370 | 3,303 | 3.5 K to 3.3 K (-6.51 %) |
| Jun 17 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.00 | 1,091 | 20,729 | 15,676 | 16.8 K to 15.7 K (-6.51 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.14 | 52 | 995 | 3,533 | 3.6 K to 3.5 K (-1.45 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.14 | 248 | 4,747 | 16,767 | 17 K to 16.8 K (-1.46 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.10 | 35 | 669 | 3,585 | 3.6 K to 3.6 K (-0.97 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.10 | 165 | 3,152 | 17,015 | 17.2 K to 17 K (-0.96 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.08 | 17 | 324 | 3,620 | 3.6 K to 3.6 K (-0.47 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.08 | 83 | 1,584 | 17,180 | 17.3 K to 17.2 K (-0.48 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.06 | 18 | 343 | 3,637 | 3.7 K to 3.6 K (-0.49 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.06 | 82 | 1,563 | 17,263 | 17.3 K to 17.3 K (-0.47 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.04 | 17 | 324 | 3,655 | 3.7 K to 3.7 K (-0.46 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.04 | 83 | 1,580 | 17,345 | 17.4 K to 17.3 K (-0.48 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.03 | 18 | 343 | 3,672 | 3.7 K to 3.7 K (-0.49 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.03 | 82 | 1,560 | 17,428 | 17.5 K to 17.4 K (-0.47 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.02 | 17 | 323 | 3,690 | 3.7 K to 3.7 K (-0.46 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.02 | 83 | 1,579 | 17,510 | 17.6 K to 17.5 K (-0.47 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.00 | 727 | 13,813 | 3,707 | 4.4 K to 3.7 K (-16.40 %) |
| Jun 12 2008 | VRUS | Pharmasset Inc | GADICKE ANSBERT | 10% Owner | Sell | S | 19.00 | 3,448 | 65,512 | 17,593 | 21 K to 17.6 K (-16.39 %) |